US Bancorp’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,954
| Closed | -$103K | – | 3975 |
|
|
2020
Q3 | $103K | Sell |
1,954
-1,104
| -36% | -$45.7K | ﹤0.01% | 2072 |
|
|
2020
Q2 | $101K | Buy |
3,058
+945
| +45% | +$30.1K | ﹤0.01% | 2104 |
|
|
2020
Q1 | $57K | Buy |
2,113
+1,927
| +1,036% | +$53.6K | ﹤0.01% | 2309 |
|
|
2019
Q4 | $4K | Hold |
186
| – | – | ﹤0.01% | 3371 |
|
|
2019
Q3 | $2K | Hold |
186
| – | – | ﹤0.01% | 3461 |
|
|
2019
Q2 | $2K | Sell |
186
-67
| -26% | -$890 | ﹤0.01% | 3506 |
|
|
2019
Q1 | $4K | Hold |
253
| – | – | ﹤0.01% | 3319 |
|
|
2018
Q4 | $3K | Sell |
253
-3,385
| -93% | -$47.1K | ﹤0.01% | 3371 |
|
|
2018
Q3 | $96K | Hold |
3,638
| – | – | ﹤0.01% | 2241 |
|
|
2018
Q2 | $74K | Sell |
3,638
-26
| -0.7% | -$558 | ﹤0.01% | 2388 |
|
|
2018
Q1 | $67K | Buy |
3,664
+67
| +2% | +$1.12K | ﹤0.01% | 2442 |
|
|
2017
Q4 | $51K | Sell |
3,597
-58
| -2% | -$784 | ﹤0.01% | 2594 |
|
|
2017
Q3 | $67K | Hold |
3,655
| – | – | ﹤0.01% | 2437 |
|
|
2017
Q2 | $62K | Hold |
3,655
| – | – | ﹤0.01% | 2438 |
|
|
2017
Q1 | $48K | Hold |
3,655
| – | – | ﹤0.01% | 2525 |
|
|
2016
Q4 | $55K | Hold |
3,655
| – | – | ﹤0.01% | 2391 |
|
|
2016
Q3 | $43K | Hold |
3,655
| – | – | ﹤0.01% | 2520 |
|
|
2016
Q2 | $39K | Buy |
3,655
+762
| +26% | +$7.86K | ﹤0.01% | 2527 |
|
|
2016
Q1 | $27K | Buy |
2,893
+2,383
| +467% | +$25.6K | ﹤0.01% | 2664 |
|
|
2015
Q4 | $8K | Sell |
510
-1,281
| -72% | -$21.4K | ﹤0.01% | 3121 |
|
|
2015
Q3 | $30K | Buy |
1,791
+137
| +8% | +$2.8K | ﹤0.01% | 2701 |
|
|
2015
Q2 | $38K | Sell |
1,654
-69
| -4% | -$1.37K | ﹤0.01% | 2671 |
|
|
2015
Q1 | $26K | Sell |
1,723
-133
| -7% | -$1.73K | ﹤0.01% | 2850 |
|
|
2014
Q4 | $22K | Sell |
1,856
-797
| -30% | -$9.11K | ﹤0.01% | 2865 |
|
|
2014
Q3 | $30K | Hold |
2,653
| – | – | ﹤0.01% | 2711 |
|
|
2014
Q2 | $32K | Sell |
2,653
-247
| -9% | -$2.92K | ﹤0.01% | 2679 |
|
|
2014
Q1 | $34K | Sell |
2,900
-104
| -3% | -$1.76K | ﹤0.01% | 2639 |
|
|
2013
Q4 | $53K | Buy |
+3,004
| New | +$50.5K | ﹤0.01% | 2389 |
|
US Bancorp's MNTA Position: Q4 2020 in Review
US Bancorp sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,954 shares — an estimated $103K sold.
US Bancorp first reported a position in MNTA in Q4 2013 and held it in 28 quarters. The position peaked at $103K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- US Bancorp reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- US Bancorp sold 1,954 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $103K.
- US Bancorp first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 28 quarters.
- US Bancorp's Momenta Pharmaceuticals, Inc. position peaked at $103K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on US Bancorp's 13F filing for Q4 2020, filed 4 Feb 2021.